| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Division of Respiratory Diseases of the University of Rome "Tor Vergata" at the National Institute for Infectious Diseases (INMI), Spallanzani Hospital, Rome, Italy. 2 Division of Pneumology, Policlinico, Modena, Italy. 3 Laboratory of Clinical Pathology, INMI, Spallanzani Hospital, and the Dept of Cell Biology, University of "Tor Vergata", Rome, Italy. 4 Tissue Typing Laboratory, University Hospital Maastricht, Maastricht, the Netherlands. 5 Pulmonary and Intensive Care, Cleveland Clinic Foundation, Cleveland, OH, USA. 6 Medical Dept, Brush Wellman Inc., Elmore, OH, USA. 7 Biostatistics Unit, IRCCS San Matteo, Pavia, Italy
CORRESPONDENCE: C. Saltini, Divisione di Malattie Respiratorie, Ospedale L. Spallanzani-I.R.C.C.S., via Portuense, 292 00149, Roma, Italy. Fax: 39 0655170413
Keywords: berylliosis, genetic susceptibility, human leukocyte antigen-DPGlu69, human leukocyte antigen-DR, tumour necrosis factor-;
Received: December 12, 2000
Accepted June 10, 2001
This work was supported by grants DE-FG02-93ER61714 and ER61714-1004058 0000196 from the Dept of Energy of the USA and grant 99060855594 from MURST, Italy.
Hypersensitivity to beryllium (Be) is found in 1–16% of exposed workers undergoing immunological screening for beryllium disease using the beryllium lymphocyte proliferation test (BeLPT). However, only
A population of 639 workers from a beryllium factory undergoing BeLPT screening was evaluated in a nested case-control study for the prevalence of HLA-DPGlu69, the HLA-DPB1, HLA-DQ and HLA-DR alleles and of the biallelic tumour necrosis factor (TNF)-;
The HLA-DPGlu69 marker was associated with "disease" (odds ratio (OR) 3.7, p=0.016, 95% confidence interval (CI) 1.4–10.0), whilst the high TNF-;
The data indicate that tumour necrosis factor-;
50% of BeLPT-positive workers present with lung granulomas (i.e. berylliosis). As berylliosis is associated with the human leukocyte antigen (HLA)-DP supratypic marker DPGlu69, the authors asked whether this marker is differentially associated with disease presentation. polymorphism TNF-;-;308 in 23 individuals presenting as "sensitized" (i.e. BeLPT-positive without lung granulomas) and in 22 presenting as "diseased" (i.e. BeLPT-positive with granulomas in the lung biopsy). production-related TNF-;-;308*2 marker was associated with both a positive BeLPT (OR 7.8, corrected p<0.0001, 95% CI 3.2–19.1) with no difference between "sensitization" and "disease". Furthermore, the HLA-DRArg74 marker was associated with "sensitization" without disease (OR 3.96, p=0.005, 95% CI 1.5–10.1). , human leukocyte antigen-DR and human leukocyte antigen-DP markers play different roles in beryllium sensitization and granuloma formation in beryllium-exposed workers.
This article has been cited by other articles:
|
|
 |
|
  D C Christiani, A J Mehta, and C-L Yu Genetic susceptibility to occupational exposures Occup. Environ. Med., June 1, 2008; 65(6): 430 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M.A. Geppert and L. W. Roberts Ethical Issues in the Use of Genetic Information in the Workplace: A Review of Recent Developments Focus, January 1, 2007; 5(4): 444 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Newman, M. M. Mroz, R. Balkissoon, and L. A. Maier Beryllium Sensitization Progresses to Chronic Beryllium Disease: A Longitudinal Study of Disease Risk Am. J. Respir. Crit. Care Med., January 1, 2005; 171(1): 54 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Maier, D. S. McGrath, H. Sato, P. Lympany, K. Welsh, R. du Bois, L. Silveira, A. P. Fontenot, R. T. Sawyer, E. Wilcox, et al. Influence of MHC CLASS II in Susceptibility to Beryllium Sensitization and Chronic Beryllium Disease J. Immunol., December 15, 2003; 171(12): 6910 - 6918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. McCanlies, K. Kreiss, M. Andrew, and A. Weston HLA-DPB1 and Chronic Beryllium Disease: A HuGE Review Am. J. Epidemiol., March 1, 2003; 157(5): 388 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Amicosante, F. Berretta, A. Franchi, P. Rogliani, C. Dotti, M. Losi, R. Dweik, and C. Saltini HLA-DP-unrestricted TNF-{alpha} release in beryllium-stimulated peripheral blood mononuclear cells Eur. Respir. J., November 1, 2002; 20(5): 1174 - 1178. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
